West Paces Advisors Inc. Johnson & Johnson Transaction History

West Paces Advisors Inc.

$408 Billion
Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, West Paces Advisors Inc. holds 2,838 shares of JNJ stock, worth $442,103. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,838

Previous 2,953 3.89%

Holding current value

$442,103

Previous $432 Million 6.56%

% of portfolio

0.11%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $16,730 - $19,248	-115 Reduced 3.89%	2,838 $460 Million
Q2 2024 Jul 16, 2024	SELL	$144.38 - $157.78 $78,687 - $85,990	-545 Reduced 15.58%	2,953 $432 Million
Q1 2024 Apr 15, 2024	SELL	$155.22 - $162.74 $22,351 - $23,434	-144 Reduced 3.95%	3,498 $553 Million
Q3 2023 Dec 18, 2023	SELL	$155.75 - $174.48 $27,567 - $30,882	-177 Reduced 4.63%	3,642 $567 Million
Q2 2023 Dec 18, 2023	SELL	$154.35 - $166.11 $4,630 - $4,983	-30 Reduced 0.78%	3,819 $632 Million
Q1 2023 Dec 18, 2023	BUY	$151.05 - $180.26 $10,422 - $12,437	69 Added 1.83%	3,849 $597 Million
Q4 2022 Dec 18, 2023	BUY	$160.2 - $179.79 $605,556 - $679,606	3,780 New	3,780 $668 Million
Q3 2022 Dec 18, 2023	SELL	$161.33 - $179.52 $5,807 - $6,462	-36 Reduced 0.98%	3,650 $596 Million
Q2 2022 Dec 18, 2023	SELL	$168.19 - $186.01 $28,424 - $31,435	-169 Reduced 4.38%	3,686 $654 Million
Q1 2022 Dec 18, 2023	BUY	$158.14 - $179.59 $33,683 - $38,252	213 Added 5.85%	3,855 $683 Million
Q4 2021 Dec 19, 2023	BUY	$155.93 - $173.01 $55,043 - $61,072	353 Added 9.72%	3,986 $682 Million
Q3 2021 Dec 19, 2023	SELL	$161.5 - $179.47 $48,611 - $54,020	-301 Reduced 7.65%	3,633 $587 Million
Q2 2021 Dec 19, 2023	SELL	$159.48 - $171.07 $122,959 - $131,894	-771 Reduced 16.39%	3,934 $648 Million
Q1 2021 Dec 19, 2023	SELL	$153.07 - $170.48 $26,940 - $30,004	-176 Reduced 3.61%	4,705 $773 Million
Q4 2020 Dec 19, 2023	SELL	$137.11 - $157.38 $370,745 - $425,555	-2,704 Reduced 35.65%	4,881 $768 Million
Q3 2020 Dec 19, 2023	SELL	$140.38 - $153.83 $147,960 - $162,136	-1,054 Reduced 12.2%	7,585 $1.13 Billion
Q2 2020 Dec 19, 2023	BUY	$128.81 - $155.51 $643,663 - $777,083	4,997 Added 137.2%	8,639 $1.21 Billion
Q1 2020 Dec 20, 2023	SELL	$111.14 - $153.99 $75,464 - $104,559	-679 Reduced 7.2%	8,755 $1.15 Billion
Q4 2019 Dec 21, 2023	SELL	$127.5 - $146.44 $22,695 - $26,066	-178 Reduced 1.9%	9,179 $1.34 Billion
Q3 2019 Dec 21, 2023	SELL	$126.95 - $142.14 $3,808 - $4,264	-30 Reduced 0.32%	9,357 $1.21 Billion
Q2 2019 Dec 21, 2023	SELL	$131.15 - $144.24 $28,328 - $31,155	-216 Reduced 2.25%	9,387 $1.31 Billion
Q1 2019 Dec 21, 2023	BUY	$125.72 - $139.79 $30,424 - $33,829	242 Added 2.59%	9,603 $1.34 Billion
Q4 2018 Dec 21, 2023	SELL	$122.84 - $147.84 $53,312 - $64,162	-434 Reduced 4.43%	9,361 $1.21 Billion
Q3 2018 Dec 20, 2023	BUY	$121.58 - $142.88 $704,191 - $827,560	5,792 Added 159.03%	9,434 $1.3 Billion
Q2 2018 Dec 21, 2023	BUY	$119.4 - $131.76 $6,805 - $7,510	57 Added 0.59%	9,795 $1.19 Billion
Q1 2018 Dec 21, 2023	BUY	$125.1 - $148.14 $8,631 - $10,221	69 Added 0.71%	9,738 $1.25 Billion
Q4 2017 Dec 21, 2023	SELL	$131.22 - $143.62 $17,452 - $19,101	-133 Reduced 1.36%	9,669 $1.35 Billion
Q3 2017 Dec 21, 2023	SELL	$129.47 - $135.38 $19,032 - $19,900	-147 Reduced 1.48%	9,802 $1.27 Billion
Q2 2017 Dec 21, 2023	BUY	N/A	2 Added 0.02%	9,949 $1.32 Billion
Q1 2017 Dec 21, 2023	BUY	N/A	966 Added 10.76%	9,947 $1.24 Billion
Q4 2016 Dec 21, 2023	BUY	N/A	5,339	8,981 $1.03 Billion

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Account

West Paces Advisors Inc. Johnson & Johnson Transaction History